0229 GMT - Bumrungrad Hospital's 3Q earnings likely grew 4.6% on year thanks to strong pent-up demand from Middle Eastern patients, says its new bull at UOB Kay Hian. The expected demand follows the Ramadan period and an earthquake that stunted travel, the analysts say. The Thai company's top line likely also grew, reversing from two quarters of decline from a lack of Kuwaiti patients, they add. That overhang is likely to be removed soon, as Bumrungrad Hospital remains a prime candidate for Kuwaiti patient referrals, the analysts note. UOB KH upgrades the stock to buy from hold and lifts its target price to THB214.00 from THB185.00. Shares last closed at THB182.00.(megan.cheah@wsj.com)

(END) Dow Jones Newswires

October 19, 2025 22:29 ET (02:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.